TY - JOUR
T1 - Mesolimbic Dopamine Function Is Related to Salience Network Connectivity
T2 - An Integrative Positron Emission Tomography and Magnetic Resonance Study
AU - McCutcheon, Robert A
AU - Nour, Matthew M
AU - Dahoun, Tarik
AU - Jauhar, Sameer
AU - Pepper, Fiona
AU - Expert, Paul
AU - Veronese, Mattia
AU - Adams, Rick A
AU - Turkheimer, Federico
AU - Mehta, Mitul A
AU - Howes, Oliver D
N1 - Copyright © 2018 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - BACKGROUND: A wide range of neuropsychiatric disorders, from schizophrenia to drug addiction, involve abnormalities in both the mesolimbic dopamine system and the cortical salience network. Both systems play a key role in the detection of behaviorally relevant environmental stimuli. Although anatomical overlap exists, the functional relationship between these systems remains unknown. Preclinical research has suggested that the firing of mesolimbic dopamine neurons may activate nodes of the salience network, but in vivo human research is required given the species-specific nature of this network.METHODS: We employed positron emission tomography to measure both dopamine release capacity (using the D2/3 receptor ligand 11C-PHNO, n = 23) and dopamine synthesis capacity (using 18F-DOPA, n = 21) within the ventral striatum. Resting-state functional magnetic resonance imaging was also undertaken in the same individuals to investigate salience network functional connectivity. A graph theoretical approach was used to characterize the relationship between dopamine measures and network connectivity.RESULTS: Dopamine synthesis capacity was associated with greater salience network connectivity, and this relationship was particularly apparent for brain regions that act as information-processing hubs. In contrast, dopamine release capacity was associated with weaker salience network connectivity. There was no relationship between dopamine measures and visual and sensorimotor networks, indicating specificity of the findings.CONCLUSIONS: Our findings demonstrate a close relationship between the salience network and mesolimbic dopamine system, and they are relevant to neuropsychiatric illnesses in which aberrant functioning of both systems has been observed.
AB - BACKGROUND: A wide range of neuropsychiatric disorders, from schizophrenia to drug addiction, involve abnormalities in both the mesolimbic dopamine system and the cortical salience network. Both systems play a key role in the detection of behaviorally relevant environmental stimuli. Although anatomical overlap exists, the functional relationship between these systems remains unknown. Preclinical research has suggested that the firing of mesolimbic dopamine neurons may activate nodes of the salience network, but in vivo human research is required given the species-specific nature of this network.METHODS: We employed positron emission tomography to measure both dopamine release capacity (using the D2/3 receptor ligand 11C-PHNO, n = 23) and dopamine synthesis capacity (using 18F-DOPA, n = 21) within the ventral striatum. Resting-state functional magnetic resonance imaging was also undertaken in the same individuals to investigate salience network functional connectivity. A graph theoretical approach was used to characterize the relationship between dopamine measures and network connectivity.RESULTS: Dopamine synthesis capacity was associated with greater salience network connectivity, and this relationship was particularly apparent for brain regions that act as information-processing hubs. In contrast, dopamine release capacity was associated with weaker salience network connectivity. There was no relationship between dopamine measures and visual and sensorimotor networks, indicating specificity of the findings.CONCLUSIONS: Our findings demonstrate a close relationship between the salience network and mesolimbic dopamine system, and they are relevant to neuropsychiatric illnesses in which aberrant functioning of both systems has been observed.
KW - Adult
KW - Cerebral Cortex/physiology
KW - Dihydroxyphenylalanine/analogs & derivatives
KW - Dopamine/metabolism
KW - Female
KW - Functional Neuroimaging
KW - Humans
KW - Magnetic Resonance Imaging
KW - Male
KW - Neural Pathways/metabolism
KW - Oxazines/metabolism
KW - Positron-Emission Tomography
KW - Ventral Striatum/metabolism
KW - Young Adult
UR - http://www.scopus.com/inward/record.url?scp=85055734196&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2018.09.010
DO - 10.1016/j.biopsych.2018.09.010
M3 - Article
C2 - 30389131
AN - SCOPUS:85055734196
SN - 0006-3223
VL - 85
SP - 368
EP - 378
JO - Biological psychiatry
JF - Biological psychiatry
IS - 5
ER -